Total raised
$8.8M
Last: SAFE 2023-07
Stage
Seed
Founded
2016
Headcount
7
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
VALFIX has created a revolutionary mitral valve repair system. The technology was designed to fully convert open heart valve surgery into a transcatheter procedure. Severe functional mitral regurgitation (FMR) affects millions of patients. Due to high surgical risks, only a small percentage of patients undergo open-heart valve surgery. Nearly half of the remaining patients, who are treated with medication only, will die within two years.
VALFIX system offers a solution to the millions of patients currently without viable treatment. VALFIX’s innovative and game-changing system allows cardiologists to perform transcatheter mitral valve repair procedures to alleviate heart failure symptoms, improve quality of life, and save lives.
Funding history · 4 rounds · $8.8M total
2023-07
SAFE
$3.6M
2019-09
Seed
$1.4M
2018-07
Pre-Seed
$600K
2017-07
Pre-Seed
$400K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
surgeonsmedical-devicessurgical-instrumentsheart-diseasesvalvescardiovascularcatheterscardiologymedical-technologiessurgery